Amneal Pharmaceuticals (AMRX) Other Operating Expenses (2017 - 2026)

Amneal Pharmaceuticals' Other Operating Expenses history runs 10 years deep, the most recent figure standing at -$700000.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 113.67% year-over-year to -$700000.0; the TTM figure through Mar 2026 stood at -$5.4 million (down 105.41% YoY), while the FY2025 annual figure was $390000.0, down 58.06% from the prior year.
• Other Operating Expenses was -$700000.0 for Q1 2026 at Amneal Pharmaceuticals, up from -$4.8 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $95.8 million in Q4 2024 to a low of -$272.4 million in Q4 2022.
• Historically, Other Operating Expenses has averaged -$32.6 million across 5 years, with a median of -$291000.0 in 2024.
• Biggest YoY gain for Other Operating Expenses was 3475.8% in 2024; the steepest drop was 7812.42% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at -$272.4 million in 2022, then surged by 98.96% to -$2.8 million in 2023, then soared by 3475.8% to $95.8 million in 2024, then slumped by 105.06% to -$4.8 million in 2025, then soared by 85.56% to -$700000.0 in 2026.
• The last three Other Operating Expenses figures came in at -$700000.0 (Q1 2026), -$4.8 million (Q4 2025), and $117000.0 (Q3 2025), per Business Quant data.